Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI
通过超极化 Xe MRI 早期检测肺部气体交换的变化
基本信息
- 批准号:8385542
- 负责人:
- 金额:$ 36.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AftercareAlveolitisBiological MarkersBiomedical TechnologyBloodBlood VesselsBlood capillariesCancer PatientCardiac OutputCardiopulmonaryChestChronicChronic DiseaseClinical ResearchDataDevelopmentDiseaseDisease ProgressionDoseEarly DiagnosisEnvironmental air flowErythrocytesEvolutionExerciseFibrosisForce of GravityFunctional ImagingGasesGoalsGoldHealthHealthcare SystemsHeterogeneityHumanHuman VolunteersImageImaging TechniquesIndividualKnowledgeLungLung diseasesMagnetic Resonance ImagingMeasurementMeasuresMethodsMicrocirculationMissionMonitorOutcomePatientsPerfusionPharmaceutical PreparationsPhasePhenotypePhysicsPositioning AttributePosturePropertyPublic HealthPulmonary Gas ExchangePulmonary function testsPulmonologyRadiationRadiation therapyReproducibilityResearchResolutionRespiratory physiologyRestScanningSpecificityStagingStructureTestingTherapeutic InterventionThree-Dimensional ImagingTimeTissuesUnited States National Institutes of HealthVisionWorkX-Ray Computed Tomographybasecapillaryclinically relevanteffective therapyhuman subjectimaging modalityimprovedinnovationinsightlung imagingpreventpublic health relevancepulmonary functionsingle photon emission computed tomographystemtooluptake
项目摘要
DESCRIPTION (provided by applicant): Arguably the biggest gap preventing progress in treating chronic pulmonary diseases is the lack of a sufficiently sensitive, comprehensive, and non-invasive means to evaluate lung function. Until this gap is filled, patients will receive medications that don't work for them, and development of new therapies will remain expensive, slow, and largely unsuccessful. The long-term goal of our research, therefore, is to develop and implement a means to image all relevant aspects of cardiopulmonary function and structure, non-invasively and longitudinally. Our approach uses hyperpolarized (HP) 129Xe MRI to image ventilation, microstructure, and gas exchange. The objective of this application is to optimize our recently demonstrated capability to image regional gas exchange by 129Xe MRI in human subjects, to use the optimized method to measure and understand resting perfusion heterogeneity, and to demonstrate the sensitivity of this imaging approach to detect changes regional lung function much earlier than currently possible. The central hypothesis is that regional gas exchange is the most sensitive marker of early changes in pulmonary function compared to available means. The rationale for the proposed research is that developing a method that can non-invasively evaluate regional gas exchange will dramatically accelerate research in pulmonary medicine by providing a more sensitive and specific measurement that can be used repeatedly. Thus, the proposed research is relevant to that part of the NIH Mission that pertains to improving health by developing and accelerating the application of biomedical technologies. Guided by strong preliminary data, the central hypothesis will be tested by pursuing three Specific Aims: 1) Optimize 3D blood-selective 129Xe gas exchange MRI 2) Establish image reproducibility as a function of time, posture, and cardiac output, and 3) Image the temporal evolution of regional gas exchange during radiation therapy. Completion of these aims will establish the utility, sensitivity and limitations of this new method compared to gold standards, while positioning it as a sensitive biomarker for research in pulmonary medicine. The first aim is expected to improve the current gas exchange image resolution 8-fold, add specificity for fibrosis, and establish the key MR physics governing the acquisition. The second aim will uncover the key determinants of the resting heterogeneity of 129Xe gas exchange already observed in preliminary studies and establish their reproducibility. The final aim brings these technical and developmental insights together to test the hypothesis that 129Xe MRI will detect alterations in gas exchange earlier than currently available means. The proposed approach is innovative because it exploits the unique properties of HP 129Xe MRI and an innovative acquisition to image lungs' most fundamental function - gas exchange. The proposed research is significant because the imaging method being developed is expected to provide a long-sought window on gas transfer into the pulmonary microcirculation as a harbinger of changing disease status.
描述(由申请人提供):可以说,阻碍慢性肺部疾病治疗进展的最大差距是缺乏足够敏感、全面和无创的方法来评估肺功能。在这一差距被填补之前,患者将接受对他们不起作用的药物,新疗法的开发将仍然昂贵,缓慢,而且基本上不成功。因此,我们研究的长期目标是开发和实施一种方法,以非侵入性和纵向方式对心肺功能和结构的所有相关方面进行成像。我们的方法使用超极化(HP)129 MRI成像通气,微观结构和气体交换。本申请的目的是优化我们最近证明的在人类受试者中通过129 μ M MRI对局部气体交换进行成像的能力,使用优化的方法来测量和了解静息灌注异质性,并证明这种成像方法的灵敏度,以比目前可能的更早地检测局部肺功能的变化。中心假设是,与现有方法相比,区域气体交换是肺功能早期变化的最敏感标志物。这项研究的基本原理是,开发一种可以无创评估区域气体交换的方法,通过提供一种可以重复使用的更灵敏、更具体的测量方法,将大大加快肺部医学的研究。因此,拟议中的研究与NIH使命的一部分有关,即通过发展和加速生物医学技术的应用来改善健康。在强有力的初步数据的指导下,将通过追求三个特定目标来检验中心假设:1)优化3D血液选择性129 μ g气体交换MRI; 2)建立图像再现性作为时间、姿势和心输出量的函数; 3)对放射治疗期间局部气体交换的时间演变进行成像。这些目标的完成将确定与金标准相比这种新方法的实用性,灵敏度和局限性,同时将其定位为肺部医学研究的敏感生物标志物。第一个目标是将当前气体交换图像分辨率提高8倍,增加纤维化特异性,并建立控制采集的关键MR物理学。第二个目标将揭示在初步研究中已经观察到的129氚气体交换的静息异质性的关键决定因素,并建立其重现性。最终的目标是将这些技术和发展的见解结合在一起,以测试129 μ M MRI将比目前可用的手段更早地检测到气体交换的变化的假设。所提出的方法是创新的,因为它利用了HP 129 MRI的独特属性和创新的采集来成像肺部最基本的功能-气体交换。拟议的研究是重要的,因为正在开发的成像方法预计将提供一个长期寻求的窗口,气体转移到肺微循环作为改变疾病状态的预兆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bastiaan Driehuys其他文献
Bastiaan Driehuys的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bastiaan Driehuys', 18)}}的其他基金
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
- 批准号:
9064201 - 财政年份:2015
- 资助金额:
$ 36.88万 - 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
- 批准号:
10390384 - 财政年份:2015
- 资助金额:
$ 36.88万 - 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
- 批准号:
10211015 - 财政年份:2015
- 资助金额:
$ 36.88万 - 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
- 批准号:
10593048 - 财政年份:2015
- 资助金额:
$ 36.88万 - 项目类别:
3D RADIAL PIPELINE FOR RECONSTRUCTION OF CLINICAL 129XE IMAGES
用于重建临床 129XE 图像的 3D 径向管道
- 批准号:
8363198 - 财政年份:2011
- 资助金额:
$ 36.88万 - 项目类别:
Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI
通过超极化 Xe MRI 早期检测肺部气体交换的变化
- 批准号:
8214524 - 财政年份:2011
- 资助金额:
$ 36.88万 - 项目类别:
Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI
通过超极化 Xe MRI 早期检测肺部气体交换的变化
- 批准号:
8025083 - 财政年份:2011
- 资助金额:
$ 36.88万 - 项目类别:
相似海外基金
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEMIC SCLEROSIS PULMONARY ALVEOLITIS
口服环磷酰胺与口服安慰剂治疗系统性硬化性肺泡炎的比较
- 批准号:
7379538 - 财政年份:2005
- 资助金额:
$ 36.88万 - 项目类别:
CYCLOPHOSPHAMIDE VS PLACEBO IN SYST SCL PULM ALVEOLITIS
环磷酰胺与安慰剂治疗 SYST SCL 肺泡炎
- 批准号:
7204972 - 财政年份:2005
- 资助金额:
$ 36.88万 - 项目类别:
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SYSTEMIC SCLEROSIS PULMONARY ALVEOLITIS
口服环磷酰胺与口服安慰剂治疗系统性硬化性肺泡炎的比较
- 批准号:
7206315 - 财政年份:2004
- 资助金额:
$ 36.88万 - 项目类别:
Cyclophosphamide vs. Placebo in Syst. Scl. Pulm. Alveolitis
环磷酰胺与安慰剂在系统中的比较。
- 批准号:
7043445 - 财政年份:2004
- 资助金额:
$ 36.88万 - 项目类别:
Alveolitis and Fibrosis in Scleroderma Lung Disease
硬皮病肺病中的肺泡炎和纤维化
- 批准号:
6574104 - 财政年份:2002
- 资助金额:
$ 36.88万 - 项目类别:
Alveolitis and Fibrosis in Scleroderma Lung Disease
硬皮病肺病中的肺泡炎和纤维化
- 批准号:
6789884 - 财政年份:2002
- 资助金额:
$ 36.88万 - 项目类别:
Alveolitis and Fibrosis in Scleroderma Lung Disease
硬皮病肺病中的肺泡炎和纤维化
- 批准号:
6662560 - 财政年份:2002
- 资助金额:
$ 36.88万 - 项目类别:
Untersuchungen zur Rolle von Fc gamma-Rezeptoren bei der Auslösung der exogenen allergischen Alveolitis (EAA) im Fc gammaRIII knock-out Mausmodell
在 Fc gammaRIII 敲除小鼠模型中研究 Fc gamma 受体在引发外源性过敏性肺泡炎 (EAA) 中的作用
- 批准号:
5181658 - 财政年份:1999
- 资助金额:
$ 36.88万 - 项目类别:
Research Grants
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SSC ALVEOLITIS
口服环磷酰胺与口服安慰剂治疗 SSC 肺泡炎
- 批准号:
6390015 - 财政年份:1999
- 资助金额:
$ 36.88万 - 项目类别:
ORAL CYCLOPHOSPHAMIDE VS ORAL PLACEBO IN SSC ALVEOLITIS
口服环磷酰胺与口服安慰剂治疗 SSC 肺泡炎
- 批准号:
6390029 - 财政年份:1999
- 资助金额:
$ 36.88万 - 项目类别: